152 related articles for article (PubMed ID: 7598820)
1. Effects of phlorizin and acipimox on insulin resistance in STZ-diabetic rats.
Kim YW; Kim JY; Lee SK
J Korean Med Sci; 1995 Feb; 10(1):24-30. PubMed ID: 7598820
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance in rats with non-insulin-dependent diabetes induced by neonatal (5 days) streptozotocin: evidence for reversal following phlorizin treatment.
Blondel O; Bailbe D; Portha B
Metabolism; 1990 Aug; 39(8):787-93. PubMed ID: 2198430
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the rise in FFA by Acipimox partially prevents GH-induced insulin resistance in GH-deficient adults.
Segerlantz M; Bramnert M; Manhem P; Laurila E; Groop LC
J Clin Endocrinol Metab; 2001 Dec; 86(12):5813-8. PubMed ID: 11739444
[TBL] [Abstract][Full Text] [Related]
4. Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients.
Bajaj M; Suraamornkul S; Romanelli A; Cline GW; Mandarino LJ; Shulman GI; DeFronzo RA
Diabetes; 2005 Nov; 54(11):3148-53. PubMed ID: 16249438
[TBL] [Abstract][Full Text] [Related]
5. Lowering plasma free fatty acids with Acipimox mimics the antidiabetic effects of the beta 3-adrenergic agonist CL-316243 in obese Zucker diabetic fatty rats.
Blachère JC; Pérusse F; Bukowiecki LJ
Metabolism; 2001 Aug; 50(8):945-51. PubMed ID: 11474483
[TBL] [Abstract][Full Text] [Related]
6. Reduction in hyperglycemia by mild food restriction in streptozotocin induced diabetic rats improves insulin sensitivity.
Cameron-Smith D; Collier GR; O'Dea K
Horm Metab Res; 1994 Jul; 26(7):316-21. PubMed ID: 7959606
[TBL] [Abstract][Full Text] [Related]
7. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects.
Santomauro AT; Boden G; Silva ME; Rocha DM; Santos RF; Ursich MJ; Strassmann PG; Wajchenberg BL
Diabetes; 1999 Sep; 48(9):1836-41. PubMed ID: 10480616
[TBL] [Abstract][Full Text] [Related]
8. Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes.
Cusi K; Kashyap S; Gastaldelli A; Bajaj M; Cersosimo E
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1775-81. PubMed ID: 17299078
[TBL] [Abstract][Full Text] [Related]
9. Effect of decreasing plasma free fatty acids by acipimox on hepatic glucose metabolism in normal rats.
Lee KU; Park JY; Kim CH; Hong SK; Suh KI; Park KS; Park SW
Metabolism; 1996 Nov; 45(11):1408-14. PubMed ID: 8931647
[TBL] [Abstract][Full Text] [Related]
10. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats.
Rossetti L; Smith D; Shulman GI; Papachristou D; DeFronzo RA
J Clin Invest; 1987 May; 79(5):1510-5. PubMed ID: 3571496
[TBL] [Abstract][Full Text] [Related]
11. Correction of chronic hyperglycemia with vanadate, but not with phlorizin, normalizes in vivo glycogen repletion and in vitro glycogen synthase activity in diabetic skeletal muscle.
Rossetti L; Lauglin MR
J Clin Invest; 1989 Sep; 84(3):892-9. PubMed ID: 2503545
[TBL] [Abstract][Full Text] [Related]
12. Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model.
Koopmans SJ; Mroz Z; Dekker R; Corbijn H; Ackermans M; Sauerwein H
Metabolism; 2006 Jul; 55(7):960-71. PubMed ID: 16784971
[TBL] [Abstract][Full Text] [Related]
13. Reducing plasma free fatty acids by acipimox improves glucose tolerance in high-fat fed mice.
Ahrén B
Acta Physiol Scand; 2001 Feb; 171(2):161-7. PubMed ID: 11350276
[TBL] [Abstract][Full Text] [Related]
14. Co-administration of etomoxir and RU-486 mitigates insulin resistance in hepatic and muscular tissues of STZ-induced diabetic rats.
Bitar MS
Horm Metab Res; 2001 Oct; 33(10):577-84. PubMed ID: 11607876
[TBL] [Abstract][Full Text] [Related]
15. Restoration of growth hormone (GH) response to GH-releasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids.
Pontiroli AE; Manzoni MF; Malighetti ME; Lanzi R
J Clin Endocrinol Metab; 1996 Nov; 81(11):3998-4001. PubMed ID: 8923850
[TBL] [Abstract][Full Text] [Related]
16. The role of resistance and aerobic exercise training on insulin sensitivity measures in STZ-induced Type 1 diabetic rodents.
Hall KE; McDonald MW; Grisé KN; Campos OA; Noble EG; Melling CW
Metabolism; 2013 Oct; 62(10):1485-94. PubMed ID: 23810201
[TBL] [Abstract][Full Text] [Related]
17. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening.
Srinivasan K; Viswanad B; Asrat L; Kaul CL; Ramarao P
Pharmacol Res; 2005 Oct; 52(4):313-20. PubMed ID: 15979893
[TBL] [Abstract][Full Text] [Related]
18. Chronic reduction of plasma free fatty acid improves mitochondrial function and whole-body insulin sensitivity in obese and type 2 diabetic individuals.
Daniele G; Eldor R; Merovci A; Clarke GD; Xiong J; Tripathy D; Taranova A; Abdul-Ghani M; DeFronzo RA
Diabetes; 2014 Aug; 63(8):2812-20. PubMed ID: 24353180
[TBL] [Abstract][Full Text] [Related]
19. Impact of streptozotocin on altering normal glucose homeostasis during insulin testing in diabetic rats compared to normoglycemic rats.
Qinna NA; Badwan AA
Drug Des Devel Ther; 2015; 9():2515-25. PubMed ID: 26005328
[TBL] [Abstract][Full Text] [Related]
20. In vivo hepatic and peripheral insulin sensitivity in rats with non-insulin-dependent diabetes induced by streptozocin. Assessment with the insulin-glucose clamp technique.
Kergoat M; Portha B
Diabetes; 1985 Nov; 34(11):1120-6. PubMed ID: 3899811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
